Do antinuclear antibodies in primary biliary cirrhosis patients identify increased risk for liver failure?

Primary Biliary Cirrhosis

Kaplan, M. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702263160907 · Cited by 2,015 · see citing works

Range of antinuclear antibodies in “healthy” individuals

Tan, E. M., Feltkamp, T. E. W., Smolen, J. S., Butcher, B. T., Dawkins, R. L., Fritzler, M. J., Gordon, T. P., Hardin, J., Kalden, J. R., Lahita, R. G., et al. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400909 · Cited by 879 · see citing works

Prognosis in primary biliary cirrhosis: Model for decision making

Dickson, R. E., Grambsch, P. M., Fleming, T. R., Fisher, L. D., & Langworthy, A. (1989) · Hepatology · doi:10.1002/hep.1840100102 · Cited by 816 · see citing works

Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)

Ludwig, J., Dickson, E. R., & McDonald, G. S. A. (1978) · Virchows Archiv A Pathological Anatomy and Histology · doi:10.1007/bf00432479 · Cited by 753 · see citing works

Primary biliary cirrhosis

Carey, E. J., Ali, A. H., & Lindor, K. D. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00154-3 · Cited by 735 · see citing works

Ursodeoxycholic acid in the treatment of primary biliary cirrhosis

Lindor, K. D., Dickson, E. R., Baldus, W. P., Jorgensen, R. A., Ludwig, J., Murtaugh, P. A., Harrison, J. M., Wiesner, R. H., Anderson, M. L., Lange, S. M., et al. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90021-3 · Cited by 487 · see citing works

Primary Biliary Cirrhosis

Kaplan, M. M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611213352107 · Cited by 455 · see citing works

Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis

Invernizzi, P., Podda, M., Battezzati, P. M., Crosignani, A., Zuin, M. G., Hitchman, E., Maggioni, M., Meroni, P. L., Penner, E., & Węsierska‐Gądek, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00040-4 · Cited by 454 · see citing works

Prevalence, kinetics, and therapeutic modulation of autoantibodies against Sp100 and promyelocytic leukemia protein in a large cohort of patients with primary biliary cirrhosis

Züchner, D., Sternsdorf, T., Szostecki, C., Heathcote, E. J., Cauch-Dudek, K., & Will, H. (1997) · Hepatology · doi:10.1053/jhep.1997.v26.pm0009362351 · Cited by 405 · see citing works

Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: Follow-up for up to 28 years

Prince, M., Chetwynd, A., Newman, W., Metcalf, J. V., & James, O. F. W. (2002) · Gastroenterology · doi:10.1053/gast.2002.36027 · Cited by 348 · see citing works

The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis

Corpechot, C., Carrat, F., Bonnand, A.-M., Poupon, R. E., & Poupon, R. (2000) · Hepatology · doi:10.1053/jhep.2000.20240 · Cited by 316 · see citing works

Primary biliary cirrhosis

Talwalkar, J. A., & Lindor, K. D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13808-1 · Cited by 299 · see citing works

Primary biliary cirrhosis with scleroderma, Raynaud's phenomenon and telangiectasia

Reynolds, T. B., Denison, E. K., Frankl, H. D., Lieberman, F. L., & Peters, R. L. (1971) · The American Journal of Medicine · doi:10.1016/0002-9343(71)90218-x · Cited by 225 · see citing works

Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis

Muratori, P., Muratori, L., Ferrari, R., Cassani, F., Bianchi, G., Lenzi, M., Rodrigo, L., Linares, A., Fuentes, D., & Bianchi, F. B. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07257.x · Cited by 204 · see citing works

Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid

Joshi, S., Cauch-Dudek, K., Wanless, I. R., Lindor, K. D., Jorgensen, R., Batts, K., & Heathcote, J. E. (2002) · Hepatology · doi:10.1053/jhep.2002.30902 · Cited by 174 · see citing works

Primary biliary cirrhosis: survival of a large cohort of symptomatic and asymptomatic patients followed for 24 years

Mahl, T. C., Shockcor, W., & Boyer, J. L. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80139-4 · Cited by 163 · see citing works

Asymptomatic primary biliary cirrhosis

Beswick, D. R., Klatskin, G., & Boyer, J. L. (1985) · Gastroenterology · doi:10.1016/0016-5085(85)90325-7 · Cited by 148 · see citing works

Scleroderma and Primary Biliary Cirrhosis

Murray-Lyon, I. M., Thompson, R. P. H., Ansell, I. D., & Williams, R. L. (1970) · BMJ · doi:10.1136/bmj.3.5717.258 · Cited by 143 · see citing works

Asymptomatic primary biliary cirrhosis: a study of its natural history and prognosis

Springer, J., Cauch-Dudek, K., O'Rourke, K., Wanless, I. R., & Heathcote, E. J. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.00770.x · Cited by 141 · see citing works

Antimitochondrial Antibodies in Primary Biliary Cirrhosis

Leung, P. S. C., Coppel, R. L., Ansari, A. A., Muñoz, S. J., & Gershwin, M. E. (1997) · Seminars in Liver Disease · doi:10.1055/s-2007-1007183 · Cited by 139 · see citing works

Overlap of autoimmune hepatitis and primary biliary cirrhosis: an evaluation of a modified scoring system

Talwalkar, J. A., Keach, J. C., Angulo, P., & Lindor, K. D. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05703.x · Cited by 127 · see citing works

Rheumatic disorders and primary biliary cirrhosis: an appraisal of 170 Italian patients

Marasini, B., Gagetta, M., Rossi, A., & Ferrari, P. A. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/ard.60.11.1046 · Cited by 123 · see citing works

Autoantibodies against a 210kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis

ITOH, S., Ichida, T., Yoshida, T., Hayakawa, A., UCHIDA, M., Tashiro‐Itoh, T., Matsuda, Y., Ishihara, K., & Asakura, H. (1998) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1998.01553.x · Cited by 117 · see citing works

Antimitochondrial antibody profiles: are they valid prognostic indicators in primary biliary cirrhosis?

Joshi, S., Cauch-Dudek, K., Heathcote, E., Lindor, K., Jorgensen, R., & Klein, R. (2002) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05620.x · Cited by 61 · see citing works

Prevalence of IgA Antibodies to Endomysium and Tissue Transglutaminase in Primary Biliary Cirrhosis

Gillett, H. R., Cauch‐Dudek, K., Healthcote, E. J. L., & Freeman, H. J. (2000) · Canadian Journal of Gastroenterology · doi:10.1155/2000/934709 · Cited by 55 · see citing works

Adaptation of the mayo primary biliary cirrhosis natural history model for application in liver transplant candidates

Kim, W., Wiesner, R., Poterucha, J. J., Therneau, T., Benson, J., Krom, R., & Dickson, E. R. (2000) · Liver transplantation · doi:10.1053/jlts.2000.6503 · Cited by 54 · see citing works

Positive markers in AMA-negative PBC

Vergani, D., & Bogdanos, D. P. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07270.x · Cited by 53 · see citing works

Results of long-term ursodiol treatment for patients with primary biliary cirrhosis

Jorgensen, R. A., Angulo, P., Dickson, E. R., & Lindor, K. D. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.06043.x · Cited by 45 · see citing works

Anti-Centromere Antibody and CREST Syndrome in Patients with Primary Biliary Cirrhosis.

Shoji, I., TAKAGI, T., & Kasukawa, R. (1992) · Internal Medicine · doi:10.2169/internalmedicine.31.1348 · Cited by 34 · see citing works

Primary Biliary Cirrhosis

Beswick, D. R., & Boyer, J. L. (1984) · Hepatology · doi:10.1002/hep.1840040710 · Cited by 22 · see citing works

Clinical significance of different antinuclear antibodies patterns in the course of primary biliary cirrhosis.

Remmel, T., Piirsoo, A., Kǒiveer, A., Remmel, H., Uibo, R., & Salupere, V. (1996) · PubMed · Cited by 22 · see citing works

The Canadian Multicenter Double‐blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis

Heathcote, J. E., Cauch-Dudek, K., Walker, V., Bailey, R. J., Blendis, L. M., Ghent, C. N., Michieletti, P., Minuk, G. Y., Pappas, C. S., Scully, L. J., et al. (1994) · Hepatology · doi:10.1002/hep.1840190512 · Cited by 2 · see citing works

Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis

Nakamura, M., Kondo, H., Mori, T., Komori, A., Matsuyama, M., Ito, M., Takii, Y., Koyabu, M., Yokoyama, T., Migita, K., et al. (2007) · Hepatology · doi:10.1002/hep.21472 · Cited by 365 · see citing works

The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines

Hirschfield, G. M., Dyson, J. K., Alexander, G. J. M., Chapman, M. H., Collier, J., Hübscher, S., Patanwala, I., Pereira, S. P., Thain, C., Thorburn, D., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315259 · Cited by 347 · see citing works

Autoimmune liver serology: Current diagnostic and clinical challenges

Bogdanos, D. P., Invernizzi, P., Mackay, I. R., & Vergani, D. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.3374 · Cited by 211 · see citing works

Ge-1 is a central component of the mammalian cytoplasmic mRNA processing body

YU, J. H., Yang, W.-H., Gulick, T., Bloch, K. D., & Bloch, D. B. (2005) · RNA · doi:10.1261/rna.2142405 · Cited by 199 · see citing works

Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis

Wesierska-Gadek, J., Penner, E., Battezzati, P. M., Selmi, C., Zuin, M., Hitchman, E., Worman, H. J., Gershwin, E. M., Podda, M., & Invernizzi, P. (2006) · Hepatology · doi:10.1002/hep.21172 · Cited by 177 · see citing works

RNA-associated protein 55 (RAP55) localizes to mRNA processing bodies and stress granules

Yang, W.-H., YU, J. H., Gulick, T., Bloch, K. D., & Bloch, D. B. (2006) · RNA · doi:10.1261/rna.2302706 · Cited by 172 · see citing works

New Treatment Paradigms in Primary Biliary Cholangitis

Levy, C., Manns, M. P., & Hirschfield, G. M. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.02.005 · Cited by 141 · see citing works

The challenges of primary biliary cholangitis: What is new and what needs to be done

Terziroli Beretta-Piccoli, B., Mieli-Vergani, G., Vergani, D., Vierling, J. M., Adams, D., Alpini, G., Banales, J. M., Beuers, U., Björnsson, E., Bowlus, C., et al. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102328 · Cited by 114 · see citing works

Guidelines for the management of primary biliary cirrhosis

Cirrhosis, W. S. (. V. F. C. P. G. F. P. B. (2014) · Hepatology Research · doi:10.1111/hepr.12270 · Cited by 111 · see citing works

Infectome: A platform to trace infectious triggers of autoimmunity

Bogdanos, D. P., Smyk, D. S., Invernizzi, P., Rigopoulou, E. I., Blank, M., Pouria, S., & Shoenfeld, Y. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.12.005 · Cited by 109 · see citing works

Interpreting serological tests in diagnosing autoimmune liver diseases

Invernizzi, P., Lleo, A., & Podda, M. (2007) · Seminars in Liver Disease · doi:10.1055/s-2007-979469 · Cited by 107 · see citing works

Antibodies to SS‐A/Ro‐52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis

GRANITO, A., MURATORI, P., MURATORI, L., PAPPAS, G., CASSANI, F., WORTHINGTON, J., FERRI, S., QUARNETI, C., CIPRIANO, V., DE MOLO, C., et al. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03433.x · Cited by 102 · see citing works

Identification of New Autoantigens for Primary Biliary Cirrhosis Using Human Proteome Microarrays

Hu, C.-J., Song, G., Huang, W., Liu, G.-Z., Deng, C., Zeng, H.-P., Wang, L., Zhang, F.-C., Zhang, X., Jeong, J. S., et al. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.015529 · Cited by 95 · see citing works

Etiopathogenesis of primary biliary cirrhosis

Lleò, A., Invernizzi, P., Mackay, I. R., Prince, H., Zhong, R., & Gershwin, M. E. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.3328 · Cited by 94 · see citing works

Disease-specific autoantibodies in primary biliary cirrhosis

Bogdanos, D. P., & Komorowski, L. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.12.019 · Cited by 93 · see citing works

Antinuclear antibodies as ancillary markers in primary biliary cirrhosis

Granito, A., Muratori, P., Quarneti, C., Παππάς, Γ., Cicola, R., & Muratori, L. (2011) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.11.82 · Cited by 86 · see citing works

Probing the mRNA processing body using protein macroarrays and "autoantigenomics"

Yang, W., & Bloch, D. B. (2007) · RNA · doi:10.1261/rna.411907 · Cited by 86 · see citing works

PML Nuclear Body Component Sp140 Is a Novel Autoantigen in Primary Biliary Cirrhosis

Granito, A., Yang, W.-H., Muratori, L., Lim, M. J., Nakajima, A., Ferri, S., Παππάς, Γ., Quarneti, C., Bianchi, F. B., Bloch, D. B., et al. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.596 · Cited by 82 · see citing works

Autoantibodies as Prognostic Markers in Autoimmune Liver Disease

Czaja, A. J. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1268-4 · Cited by 77 · see citing works

Mechanisms of tissue injury in autoimmune liver diseases

Liaskou, E., Hirschfield, G. M., & Gershwin, M. E. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0439-3 · Cited by 73 · see citing works

Update on primary biliary cirrhosis

Invernizzi, P., Selmi, C. F., & Gershwin, M. E. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.02.014 · Cited by 70 · see citing works

Clinical Significance of Autoantibodies in Primary Biliary Cirrhosis

Nakamura, M. (2014) · Seminars in Liver Disease · doi:10.1055/s-0034-1383732 · Cited by 69 · see citing works

Diagnostic and clinical significance of anti-centromere antibodies in primary biliary cirrhosis

Liberal, R., Grant, C. R., Sakkas, L. I., Bizzaro, N., & Bogdanos, D. P. (2013) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2013.04.005 · Cited by 65 · see citing works

Clinical significance of the fluctuation of primary biliary cirrhosis-related autoantibodies during the course of the disease

Gatselis, N., Zachou, K., Norman, G., Gabeta, S., Papamichalis, P., Koukoulis, G., & Dalekos, G. (2013) · Autoimmunity · doi:10.3109/08916934.2013.801461 · Cited by 67 · see citing works

Clinical Epidemiology of Primary Biliary Cirrhosis

Lazaridis, K. N., & Talwalkar, J. A. (2007) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000225653.07932.8f · Cited by 63 · see citing works

B-cell involvement in chronic graft-versus-host disease

Kapur, R., Ebeling, S. B., & Hagenbeek, A. (2008) · Haematologica · doi:10.3324/haematol.13311 · Cited by 56 · see citing works

Epstein-Barr Virus as a Trigger of Autoimmune Liver Diseases

Rigopoulou, E. I., Smyk, D. S., Matthews, C. E., Billinis, C., Burroughs, A. K., Lenzi, M., & Bogdanos, D. P. (2012) · Advances in Virology · doi:10.1155/2012/987471 · Cited by 55 · see citing works

Value of Autoantibody Analysis in the Differential Diagnosis of Chronic Cholestatic Liver Disease

Milkiewicz, P., Buwaneswaran, H., Coltescu, C., Shums, Z., Norman, G. L., & Heathcote, E. J. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.07.012 · Cited by 47 · see citing works

Autoantibodies to GW bodies and other autoantigens in primary biliary cirrhosis

Stinton, L. M., Swain, M., Myers, R. P., Shaheen, A., & Fritzler, M. (2011) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2010.04288.x · Cited by 49 · see citing works

Natural History of Primary Biliary Cirrhosis

Mayo, M. J. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.02.012 · Cited by 45 · see citing works

The value of antinuclear antibodies in primary biliary cirrhosis

Gao, L., Tian, X., Liu, B., & Zhang, F. (2008) · Clinical and Experimental Medicine · doi:10.1007/s10238-008-0150-6 · Cited by 44 · see citing works

Primary Biliary Cirrhosis: Family Stories

Smyk, D. S., Cholongitas, Ε., Kriese, S., Rigopoulou, E. I., & Bogdanos, D. P. (2011) · Autoimmune Diseases · doi:10.4061/2011/189585 · Cited by 38 · see citing works

The Significance of Autoantibody Changes Over Time in Primary Biliary Cirrhosis

Tana, M. M.-S., Shums, Z., Milo, J. L., Norman, G. L., Leung, P. S. C., Gershwin, M. E., Noureddin, M., Kleiner, D. E., Zhao, X., Heller, T., et al. (2015) · American Journal of Clinical Pathology · doi:10.1309/ajcpqv4a7qaeefev · Cited by 38 · see citing works

Tracing environmental markers of autoimmunity: introducing the infectome

Bogdanos, D. P., Smyk, D. S., Invernizzi, P., Rigopoulou, E. I., Blank, M., Sakkas, L. I., Pouria, S., & Shoenfeld, Y. (2013) · Immunologic Research · doi:10.1007/s12026-013-8399-6 · Cited by 37 · see citing works

Risk Factors and Prediction of Long-term Outcome in Primary Biliary Cirrhosis

Ishibashi, H., Komori, A., Shimoda, S., Ambrosini, Y. M., Gershwin, M. E., & Nakamura, M. (2011) · Internal Medicine · doi:10.2169/internalmedicine.50.4462 · Cited by 36 · see citing works

Autoantibody profiling of patients with primary biliary cirrhosis using a multiplexed line-blot assay

Villalta, D., Sorrentino, M. C., Girolami, E., Tampoia, M., Alessio, M. G., Brusca, I., Daves, M., Porcelli, B., Barberio, G., & Bizzaro, N. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.08.024 · Cited by 35 · see citing works

Predictive role of anti‐gp210 and anticentromere antibodies in long‐term outcome of primary biliary cirrhosis

Nakamura, M., Komori, A., Ito, M., Kondo, H., Aiba, Y., Migita, K., Nagaoka, S., Ohata, K., Yano, K., Abiru, S., et al. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00244.x · Cited by 34 · see citing works

Role of autoantibodies in the clinical management of primary biliary cholangitis

Rigopoulou, E. I., & Bogdanos, D. P. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i12.1795 · Cited by 30 · see citing works

Current Concepts in Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis

Sclair, S. N., Little, E. C., & Levy, C. (2015) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2015.33 · Cited by 33 · see citing works

Primary biliary cirrhosis in adults

Momah, N., & Lindor, K. D. (2014) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2014.888950 · Cited by 33 · see citing works

Not all autoantibodies are clinically relevant. Classic and novel autoantibodies in Sjögren’s syndrome: A critical review

Vílchez-Oya, F., Balastegui-Martín, H., García-Martínez, E., & Corominas, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1003054 · Cited by 31 · see citing works

Molecular diagnostics of primary biliary cirrhosis

Rigopoulou, E. I., & Dalekos, G. N. (2008) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2.6.621 · Cited by 28 · see citing works

Risk factors for hepatic decompensation in patients with primary biliary cirrhosis.

Shi, T.-Y., Zhang, L.-N., Chen, H., Wang, L., Shen, M., Zhang, X., & Zhang, F.-C. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i7.1111 · Cited by 29 · see citing works

Characterization of Autoantibodies against Components of the Nuclear Pore Complexes

Węsierska‐Gądek, J., KLIMA, A., Komina, O., Ranftler, C., Invernizzi, P., & Penner, E. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1398.058 · Cited by 26 · see citing works

Natural history of primary biliary cirrhosis

Abe, M., & Onji, M. (2008) · Hepatology Research · doi:10.1111/j.1872-034x.2008.00351.x · Cited by 25 · see citing works

Peri-nuclear antibodies correlate with survival in Greek primary biliary cirrhosis patients

Sfakianaki, O. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i39.4938 · Cited by 21 · see citing works

LMKB/MARF1 Localizes to mRNA Processing Bodies, Interacts with Ge-1, and Regulates IFI44L Gene Expression

Bloch, D. B., Li, P., Bloch, E. G., Berenson, D. F., Galdos, R. L., Arora, P. K., Malhotra, R. K., Wu, C., & Yang, W.-H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094784 · Cited by 18 · see citing works

Diagnostic and Clinical Value of Specific Autoantibodies against Kelch-like 12 Peptide and Nuclear Envelope Proteins in Patients with Primary Biliary Cholangitis

Bauer, A., Habior, A., & Gaweł, D. (2022) · Biomedicines · doi:10.3390/biomedicines10040801 · Cited by 15 · see citing works

Recommendations for evaluation and diagnosis of extra-glandular manifestations of primary Sjögren syndrome: results of an epidemiologic systematic review/meta-analysis and a consensus guideline from the Brazilian society of rheumatology (hepatic, gastrointestinal and pancreatic)

Trevisani, V. F., Pinheiro, A., Fialho, S. C. D. M. S., Fernandes, M., Pugliesi, A., Pasoto, S., Lopes, M. L., Guedes, L., Miyamoto, S., dos Santos, L. C., et al. (2022) · Advances in Rheumatology · doi:10.1186/s42358-022-00267-y · Cited by 10 · see citing works

Clinical influences of anticentromere antibody on primary Sjögren’s syndrome in a prospective Korean cohort

Park, Y., Lee, J. J., Koh, J. H., Choe, J., Sung, Y., Lee, S., Kim, J., Park, S., & Kwok, S. (2020) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2020.146 · Cited by 15 · see citing works

Current concepts in the pathogenesis of primary biliary cirrhosis

Charatcharoenwitthaya, P., & Lindor, K. D. (2005) · Annals of Hepatology · doi:10.1016/s1665-2681(19)32061-7 · Cited by 15 · see citing works

GW/P-Bodies and Autoimmune Disease

Bloch, D. B., Nobre, R. A., & Yang, W.-H. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5107-5_5 · Cited by 14 · see citing works

The prognostic value of anti-gp210 and anti-centromere antibodies in patients with primary biliary cholangitis: Enhancing the prognostic utility on the GLOBE scoring system

Ding, D., Jia, G., Cui, L., Liu, Y., Wang, X., Sun, R., Deng, J., Guo, G., Shang, Y., & Han, Y. (2025) · Digestive and Liver Disease · doi:10.1016/j.dld.2024.12.024 · Cited by 13 · see citing works

Clinical Characteristics of Patients with Hepatitis C Virus-Related Chronic Liver Disease Seropositive for Anticentromere Antibody

Himoto, T., Nakai, S., Kinekawa, F., Yoneyama, H., Deguchi, A., Kurokochi, K., Masaki, T., Senda, S., Haba, R., Watanabe, S., et al. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-008-0359-y · Cited by 13 · see citing works

Clinical characteristics of patients with autoimmune hepatitis seropositive for anticentromere antibody

Himoto, T., Murota, M., Yoneyama, H., Deguchi, A., Kurokochi, K., Senda, S., Haba, R., Watanabe, S., Nishioka, M., & Masaki, T. (2010) · Hepatology Research · doi:10.1111/j.1872-034x.2010.00684.x · Cited by 12 · see citing works

Serum autoantibodies for the diagnosis and management of autoimmune liver diseases

Achenza, M. I. S., Meda, F., Brunetta, E., & Selmi, C. F. (2012) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.12.58 · Cited by 11 · see citing works

Autoantibodies to speckled protein family in primary biliary cholangitis

Granito, A., Muratori, L., Tovoli, F., & Muratori, P. (2021) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-021-00539-0 · Cited by 11 · see citing works

The prognostic value of antibodies to gp210 among patients with primary biliary cholangitis in Northeast China.

Chen, Q., Zhong, R., Dong, K., Wang, Y., Kui, Y., Ma., B.-S., Wen, X., & Jin, Q. (2021) · Digestive and Liver Disease · doi:10.1016/j.dld.2021.10.011 · Cited by 11 · see citing works

Predicting and preventing autoimmunity: the case of anti-mitochondrial antibodies

Milkiewicz, M., Caballería, L., Smyk, D. S., & Milkiewicz, P. (2012) · Autoimmunity Highlights · doi:10.1007/s13317-012-0038-z · Cited by 11 · see citing works

DETECTION OF ANTI-SP100 ANTIBODIES IN PRIMARY BILIARY CIRRHOSIS. COMPARISON OF ELISA AND IMMUNOFLUORESCENCE

Bauer, A., Habior, A., & Kraszewska, E. (2012) · Journal of Immunoassay and Immunochemistry · doi:10.1080/15321819.2012.741088 · Cited by 10 · see citing works

S3-Leitlinie „Seltene Lebererkrankungen (LeiSe LebEr) – Autoimmune Lebererkrankungen von der Pädiatrie bis zum Erwachsenenalter“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS)

Autorinnen/Autoren, & Collaborators (2025) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2558-5204 · Cited by 6 · see citing works

Clinical Guideline of Primary Biliary Cirrhosis 2012 The Intractable Hepato-Biliary Disease Study Group supported by the Ministry of Health, Labour and Welfare of Japan

Ishibashi, H., Nakanuma, Y., Ueno, Y., Egawa, H., Koike, K., Komori, A., Sakisaka, S., Shimoda, S., Shirabe, K., Zeniya, M., et al. (2012) · Kanzo · doi:10.2957/kanzo.53.633 · Cited by 6 · see citing works

Implicación pronóstica de las manifestaciones clínicas extrahepáticas, autoinmunidad y capilaroscopia ungueal microscópica en pacientes con cirrosis biliar primaria

Marí-Alfonso, B., Amengual, M. J., Vergara, M., Simeón‐Aznar, C. P., Fonollosa‐Pla, V., Jove-Buxeda, E., Oliva-Morera, J., & Tolosa-Vilella, C. (2015) · Medicina Clínica · doi:10.1016/j.medcli.2015.02.026 · Cited by 5 · see citing works

Primary Biliary Cirrhosis

Invernizzi, P., Leung, P. S. C., Ma, X., & Gershwin, M. E. (2013) · Springer eBooks · doi:10.1007/978-3-319-02096-9_18 · Cited by 5 · see citing works

Popular and unpopular infectious agents linked to primary biliary cirrhosis

Koutsoumpas, A. L., Kriese, S., & Rigopoulou, E. I. (2012) · Autoimmunity Highlights · doi:10.1007/s13317-012-0039-y · Cited by 4 · see citing works

Autoantibodies in the diagnostics, prognostics and follow-up of primary biliary cholangitis

Antal‐Szalmás, P., Bencze, D., Demeter, S., Pénzes, K., Szabó, L., Tóth, B., Földesi, R., Papp, M., & Nagy, G. (2026) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2026.100366 · Cited by 2 · see citing works

Update der S3-Leitlinie „Seltene Lebererkrankungen (LeiSe LebEr) – Autoimmune Lebererkrankungen von der Pädiatrie bis zum Erwachsenenalter“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – Living guideline

Sebode, M., Bantel, H., Baumann, U., Bufler, P., Demir, M., Dold, L., Keitel, V., Klein, R., Kremer, A. E., Jansen, P. L., et al. (2026) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2769-2475 · Cited by 2 · see citing works

Prognostic implications of extra-hepatic clinical manifestations, autoimmunity and microscopic nail capillaroscopy in patients with primary biliary cirrhosis

Marí-Alfonso, B., Amengual, M. J., Vergara, M., Simeón‐Aznar, C. P., Fonollosa‐Pla, V., Jove-Buxeda, E., Oliva-Morera, J., & Tolosa-Vilella, C. (2016) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2016.04.035 · Cited by 2 · see citing works

Fluctuations of antimitochondrial antibodies and anti-gp210 antibody in a patient with primary biliary cholangitis and Sjögren syndrome with subsequent autoimmune hemolytic anemia

Zhao, D., Liu, Y., Han, Y., Zhang, H., Zhao, Y., & Yan, H. (2020) · Medicine · doi:10.1097/md.0000000000018856 · Cited by 2 · see citing works

Cirrhose biliaire primitive et sclérodermie systémique : aspects cliniques, biologiques et pronostiques

Koenig, M., Joyal, F., Vincent, C., Fritzler, M. J., Poliquin, M., Dominguez, M., & Senécal, J. (2008) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2008.10.219 · Cited by 1 · see citing works

Primary Biliary Cholangitis: Its Science and Practice

Wang, L., Bowlus, C. L., Wang, F., & Gershwin, M. E. (2017) · Springer eBooks · doi:10.1007/978-3-319-50168-0_8 · Cited by 1 · see citing works

Primary Biliary Cirrhosis

Dancygier, H. (2009) · Springer eBooks · doi:10.1007/978-3-642-04519-6_19

Identifizierung immundominanter Epitope der Pyruvatdehydrogenase als Targetantigen antimitochondrialer Antikörper bei der primär-biliären Zirrhose und ihre klinische Relevanz

Medizin, A. I., & Kanz, L. (2012)

Auto-anticuerpos en las enfermedades hepáticas

Aj, M. L., & Angulo, P. (2007) · Revista Portuguesa de Pneumologia

Correlation of Anti-mitochondrial Antibodies with Liver Histology and Outcomes

Tan, S. Y., Movahedi, Z., Beisel, J. C., Ayutyanont, N., & Nadir, A. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4094-5

Anti-centromere Antibody-positive Primary Biliary Cirrhosis with Rapid Development

Suzuki, Y., Abe, M., Hosoki, Y., Miyoshi, S., Inoue, M., Ohhira, M., Ohtake, T., & Kohgo, Y. (2008) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.97.144

Antimitochondrial and antinuclear antibodies in primary biliary cirrhosis** Przeciwciała antymitochondrialne i antyjądrowe w pierwotnej żółciowej marskości wątroby

Bauer, A., & Czarnocka, B. (2011)

Autoimmune liver damage in patients with primary Sjogren's syndrome associated with anticentromeric antibodies

Chaltsev, B. D., Vasiliev, V., Palshina, S. G., Torgashina, A. V., Владимировна, С. Е., Khvan, Y. I., Rodionova, E. B., Safonova, T. N., & Некрасова, Т. П. (2021) · Modern Rheumatology Journal · doi:10.14412/1996-7012-2021-3-27-34

Autoantibodies in Primary Biliary Cirrhosis

Komori, A. (2014) · Springer eBooks · doi:10.1007/978-4-431-54789-1_17

Anti-Centromere Antibody-positive Primary Biliary Cirrhosis with Rapid Development

泰猛, 山., & 康秋, 鈴. (2008) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.97.1105

Evolving paradigms in primary biliary cholangitis: from molecular mechanisms to personalized therapeutics with seladelpar, elafibranor, and beyond

Qasim, B., Kumari, H., Kashif, S. N., Abbas, S. M. I., Hani, O., Salma, O., Sauleh, A., Adnan, F., Ali, M., Raheem, A., et al. (2025) · Egyptian Liver Journal · doi:10.1186/s43066-025-00464-6

Quantification et caractérisation des maladies auto-immunes et allergiques à l'aide de méthodes d'apprentissage profond

Martinroche, G. (2024) · theses.fr (ABES) · doi:10.70675/7aeee875z2286z46d5z98e4z51e699b8b387

Porto‐Sinusoidal Vascular Disorder‐Spectrum Portal Venopathy as a Structural Substrate for Portal Hypertension in Anti‐Centromere Antibody‐Positive Primary Biliary Cholangitis

Ando, Y., Mabuchi, S., Nakayama, S., Honda, A., Hokari, R., Harada, K., & Murashima, N. (2026) · Pathology International · doi:10.1111/pin.70179

Predictors of liver failure in primary biliary cirrhosis

Zhao, P., Liu, W. W., Li, J., Wang, C., Wang, H., Xu, J., Wang, R., Yang, H., Jin, C. S., & Wei, Z. (2014) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2014.985763 · Cited by 7 · see citing works

Upsala Journal of Medical Sciences. 2015; 120: 47–51 ORIGINAL ARTICLE Predictors of liver failure in primary biliary cirrhosis

Zhao, P., Liu, W.-W., Li, J.-F., Wang, C.-Y., Wang, H., Xu, J., Wang, R.-F., Yang, H.-Z., Jin, C., & 魏振满 (2016)

Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis

Nakamura, M., Kondo, H., Mori, T., Komori, A., Matsuyama, M., Ito, M., Takii, Y., Koyabu, M., Yokoyama, T., Migita, K., et al. (2007) · Hepatology · doi:10.1002/hep.21472 · Cited by 365 · see citing works

Predictive role of anti‐gp210 and anticentromere antibodies in long‐term outcome of primary biliary cirrhosis

Nakamura, M., Komori, A., Ito, M., Kondo, H., Aiba, Y., Migita, K., Nagaoka, S., Ohata, K., Yano, K., Abiru, S., et al. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00244.x · Cited by 34 · see citing works

Clinical significance of different antinuclear antibodies patterns in the course of primary biliary cirrhosis.

Remmel, T., Piirsoo, A., Kǒiveer, A., Remmel, H., Uibo, R., & Salupere, V. (1996) · PubMed · Cited by 22 · see citing works